An experimental treatment involving stem cells from umbilical cords could significantly reduce deaths and quicken recovery time for patients suffering the most severe form of Covid-19, a study suggests.
US researchers reported a 91 per cent survival rate in seriously ill patients given the stem cell infusion, compared to 42 per cent in a second group who did not receive the treatment.
Maybe this is a “scientific first” for Sanford Burnham Presby Medical Discovery Institute but not for Nova Cells Institute of Mexico (NCIM) which introduced a stem cell homing compound it created back in 2015! Dubbed the “Beacon Factor” you can read about it here and in a July 2015 blog entry here.
NCIM introduced its stem cell homing “Beacon Factor” in 2015. Sanford Burnham Presby Medical Discovery Institute announced their stem cell homing creation this year, 2020. five years after NCIM. Five years. Better late than never comes to mind. This and “such hubris”….. to call SBPDI’s latecomer a “scientific first” , that is.
Nova Cells Institute of Mexico: the little guys who have made progress on a shoestring budget, egged on by an overwhelming desire to revolutionize healthcare…..one (patient) turnaround at a time.
If you need help with questions or concerns about stem cell therapies, NCIM’s proprietary Beacon Factor, patient responses to treatment, or just about anything else then grab your phone or keyboard and contact NCIM.
Nova Cells Institute has never worked with embryonic or fetal stem cells, and never will. Embryonic and fetal stem cells can produce tumors (These are classified as pluripotent” which means they can form teratomas and other tumors in certain instances such as being injected into the central nervous system). The adult stem cells Nova Cells uses (umbilical cord, Wharton’s Jelly, placenta-derived, and a patient’s own bone marrow) are “multipotent” which limits the body cell types they can become (These stem cells do not form teratomas or such. Some private stem cell clinics in Europe and the US have injected adult stem cells into organs such as kidneys and eyes which caused problems and complications. Nova Cells Institute has never injected stem cells into an organ). Let’s be very clear about these points and a few others:
(1) Nova Cells was established in 2009. There are other companies that came along later on which use “Nova” in their company title, but these are NOT affiliated in any way with Nova Cells Institute of Mexico (NCIM).
(2) Nova Cells Institute has never used embryonic or fetal stem cells and never will (They can form tumors under certain circumstances).
(3) Nova Cells Institute only uses multipotent adult stem cells derived from umbilical cord blood, Wharton’s Jelly, placental tissue, and a patient’s own bone marrow.
(4) Nova Cells Institute administers stem cells by intravenous drip (On rare occasions Nova Cells affiliated doctors recommend an intrathecal or spinal tap infusion of cells. Everything related to this is spelled out, a process called “informed consent”. Patients who prefer not to do this are given cells by intravenous or IV drip).
During August one of Nova Cell’s MDs discovered to his own chagrin that his diabetic spawned neuropathy had progressed to the point he could no longer feel his own feet! He then did a single intravenous treatment with primed umbilical cord stem cells and the “Beacon Factor”. Within a week all sensation had returned to his feet and all other neuropathy symptoms were gone.
Nova Cells uses only certifiably disease free umbilical cord stem cells and those from Wharton’s Jelly, and sometimes a patient’s own bone marrow stem cells, all of which are processed in Mexico in a state-of-the-art laboratory run by our firm’s director of laboratory services, Dr. Abel Pena (Photo above).
Dr. Pena, who is a biochemist, was trained by a leading US stem cell biologist and maintains the highest levels of safety and hygiene in his lab in Tijuana. In addition, he has pioneered numerous methods for priming stem cells; that is, getting them to respond to chemical signals in target tissues by becoming cells that tend to effect or support healing or relief. Stem cells primed using his methods have produced impressive, sometimes remarkable clinical responses in people with a wide variety of neurologic & other diseases and conditions.